The direction for US stocks on Thursday was constantly shifting ahead of the opening bell, as overnight optimism over US-Iran negotiations and another blockbuster quarter for Nvidia were not enough to set a clear path. Futures pointed down in the early hours, turned green and then back to...
The direction for US stocks on Thursday was constantly shifting ahead of the opening bell, as overnight optimism over US-Iran negotiations and another blockbuster quarter for Nvidia were not enough to set a clear path. Futures pointed down in the early hours, turned green and then back to...
GOP races to fund immigration enforcement. And, U.S. indicts former Cuban president Good morning. You're reading the Up First newsletter. Subscribe here to get it delivered to your inbox, and listen to the Up First podcast for all the news you need to start your day. Today's top stories Republicans in Congress are racing to approve $72 billion in funding for Immigration and Customs Enforcement and...
GOP races to fund immigration enforcement. And, U.S. indicts former Cuban president Good morning. You're reading the Up First newsletter. Subscribe here to get it delivered to your inbox, and listen to the Up First podcast for all the news you need to start your day. Today's top stories Republicans in Congress are racing to approve $72 billion in funding for Immigration and Customs Enforcement and Customs and Border Patrol through the rest of President Trump's term. The GOP is using a tool known as budget reconciliation to bypass Democrats who oppose more agency funding without reforms that limit officers' tactics. Trump is unhappy with the package because it doesn't include funding for the White House ballroom. Several Republicans, including Louisiana Sen. Bill Cassidy, said they would oppose the budget if it included ballroom funding. Cassidy just lost his primary after the president backed another candidate. The senator remains a voting member of Congress until January. toggle caption Heather Diehl/Getty Images 🎧 Congressmembers like Cassidy have the opportunity to disrupt the status quo on their way out of their positions, NPR's Sam Gringlas tells Up First. Other members who aim to stay in office are less likely to defy the president. So far, Cassidy has opposed the ballroom funding and cast the crucial vote to advance the Iran war powers resolution, despite having opposed it in the past. Sen. Lisa Murkowski of Alaska, a Republican known for frequently breaking with Trump, pointed out that the president may have forgotten that he needs Congress to advance his agenda. She added that Trump's attacks on incumbent Republicans could backfire and harm the party's chances in November. on their way out of their positions, NPR's Sam Gringlas tells Up First. Other members who aim to stay in office are less likely to defy the president. So far, Cassidy has opposed the ballroom funding and cast the crucial vote to advance the Iran war powers resolution, despite having oppos...
Tim Robberts/DigitalVision via Getty Images I rate Monolithic Power Systems ( MPWR ) stock a Hold/Avoid. Monolithic Power has a single-seller-like edge in AI thermodynamics through its Z-Axis Power Delivery [ZPD] and 40/45nm BCD node shrink that is driving hyper-growth in both the Enterprise Data and Comms (optical module) segments. However, the stock's hyper-premium valuation (61x forward P/E) pr...
Tim Robberts/DigitalVision via Getty Images I rate Monolithic Power Systems ( MPWR ) stock a Hold/Avoid. Monolithic Power has a single-seller-like edge in AI thermodynamics through its Z-Axis Power Delivery [ZPD] and 40/45nm BCD node shrink that is driving hyper-growth in both the Enterprise Data and Comms (optical module) segments. However, the stock's hyper-premium valuation (61x forward P/E) prices-in software-like margin expansion. The reasoning for a Hold is that Monolithic’s shift to integrated Intelli-Phase power modules can cap gross margins in the mid-50s due to the low-margin physics of raw substrate and copper packaging. More so, about major risks to this thesis, there is an upside risk of physical AI (robotics) adoption accelerating faster than expected that is offsetting margin drags. Whereas the downside risk is of large multiple compression as Wall Street sentiment loses to flatlining gross margins, possible CSP second-sourcing in 48V architectures, and Monolithic's blind spots in rack-level 800V SiC/GaN power distribution. What business does Monolithic Power Systems do? Monolithic is not a power-chip provider, first of all, it is fastly becoming a sub-system module provider targeting physical bottlenecks that semiconductor giants [like Nvidia ( NVDA ), AMD ( AMD ), and Broadcom ( AVGO )] do not solve themselves. What Can Take Monolithic Power Systems' Stock Price Higher? I am not focusing on what is already known, that Monolithic Power Systems is a main derivative play on AI accelerators, as it is already trading ($1,468.11, at the time of writing) at a hyper-premium 61.12x forward non-GAAP P/E. In my opinion, MPWR stock’s momentum points out that Wall Street has already priced-in the Q1-FY2026 Enterprise Data revenue surge of +97.7% Y/Y and the raised 2026 segment growth floor from 50% to 85%. To assess the possibility of forward alpha at a $72.13 billion mCap, I am leaving surface-level TAM extrapolations in trash and focusing on Monolithic’s base ...
The ‘Anti-Weaponization Fund’ is an extraordinary example of bald self-dealing Donald Trump is stealing almost $2bn in taxpayer money and handing it out to his friends. That’s the upshot of the president’s recent agreement following a $10bn lawsuit he brought in his personal capacity against the IRS, an agency that he oversees. Trump brought the suit over leaks of some documents from his tax retur...
The ‘Anti-Weaponization Fund’ is an extraordinary example of bald self-dealing Donald Trump is stealing almost $2bn in taxpayer money and handing it out to his friends. That’s the upshot of the president’s recent agreement following a $10bn lawsuit he brought in his personal capacity against the IRS, an agency that he oversees. Trump brought the suit over leaks of some documents from his tax returns to the press. To resolve the suit, the justice department will create a fund of nearly $1.8bn – a wildly outsized figure compared with Trump’s somewhat flimsily alleged injuries – that can be doled out to Trump allies. The Guardian describes the fund as “loosely controlled and secretive”, but members of the Trump administration have not ruled out January 6 i nsurrectionists as possible awardees. The so-called “Anti-Weaponization Fund” will be administered by four commissioners appointed by Trump’s attorney general and one appointed “in consultation” with congressional leadership – Trump, who can fire the commissioners, will have ultimate control. It will have the authority to issue formal apologies for alleged mistreatment of conservative political actors by previous administrations – ie, those few who were prosecuted or sued during the Biden era. When Trump leaves office, any remaining money will not be available for his successor to use similarly, but will instead be distributed back to the federal government. But I doubt that there will be any remaining money. We may never know either way: there is no requirement that the fund’s work be made public, and required reports to the attorney general on its conduct are to be confidential. In addition to the creation of this massive slush fund, the agreement also requires that the IRS drop all audits of Trump and his family. Moira Donegan is a Guardian US columnist Continue reading...
A Mancunian singer-songwriter becomes a viral divisive figure while trying to track down a girl called Emily Last week came the news that gen Z are big fans of going to the cinema. Now here’s a gen Z romcom from Working Title, the company behind Bridget Jones’s Diary and Notting Hill. Directed by Alicia MacDonald from a script by Rachel Hirons, Finding Emily shares DNA with Richard Curtis’s comedi...
A Mancunian singer-songwriter becomes a viral divisive figure while trying to track down a girl called Emily Last week came the news that gen Z are big fans of going to the cinema. Now here’s a gen Z romcom from Working Title, the company behind Bridget Jones’s Diary and Notting Hill. Directed by Alicia MacDonald from a script by Rachel Hirons, Finding Emily shares DNA with Richard Curtis’s comedies – the same warm heart and charm, plus levels of cheesiness that some may find cringe. In the end I found it impossible to hate, though one or two performances felt a bit lacking in comic flair. It’s set in Manchester, where indie singer-songwriter Owen (Spike Fearn) meets undergraduate Emily (Sadie Soverall) at the student union. They click, but when Emily taps her number into his phone, she misses out a digit. Is it a drunken error, or has she wrong-numbered him? Owen is convinced it’s a mistake and sticks up posters around campus to find her. After a tipoff, he waits outside a lecture hall for psychology student Emily (Angourie Rice). She’s American, and not his Emily, but she offers to help, suggesting Owen emails every Emily enrolled at the university – all 318 of them. Owen accidentally sends the email to all rather than BCCing, creating an email group of Emilies who are divided in their reactions. Is he some kind of creepy virgin “incel”? Or a diehard romantic? Owen becomes a meme: “email guy”. Continue reading...
My wine consultant friend, Ruth Osborne, often wears a cap embroidered with the words “chenin blanc”. As someone who is proud to include hats from Toad bakery and Celine Dion’s 2017 UK tour in her collection, I know all about headwear as a signifier of personal brand, and Ruth isn’t the only person in the business to extol the virtues of chenin. But why? The Guardian’s journalism is independent. W...
My wine consultant friend, Ruth Osborne, often wears a cap embroidered with the words “chenin blanc”. As someone who is proud to include hats from Toad bakery and Celine Dion’s 2017 UK tour in her collection, I know all about headwear as a signifier of personal brand, and Ruth isn’t the only person in the business to extol the virtues of chenin. But why? The Guardian’s journalism is independent. We will earn a commission if you buy something through an affiliate link. Learn more. Chenin blanc shape-shifts with soil and climate perhaps more than any other grape, and it is this chameleon quality that sets wine enthusiasts aflutter, as does the fact that it’s a late-ripening variety with good acidity, so lends itself to a whole spectrum of profiles, from dry to sweet. Versatile, aesthetically ambiguous and, as my friend’s hat testifies, cultish in its appeal, it is the Tilda Swinton of grapes. With up to 35,000 hectares of the stuff planted worldwide, it is a global grape, too. But, unlike the leading players such as chardonnay and cabernet sauvignon, chenin is associated with very defined areas. In South Africa, which grows more than half the world’s crop, it runs the gamut from mass-produced and affordable to premium and terroir-driven. France, meanwhile, has about a third of the world’s chenin vines, over 90% of them in the Loire valley; there are also small parcels in the US, Australia and South America, though you might struggle to find much in common between them beyond being broadly definable as “white wine”. Take the Loire, where the appellations of Vouvray and Savennières sit just 80 miles apart, but produce chenins that are chalk and cheese (or, rather, chalk and schist – the rocks that characterise their respective soil types and, in turn, the flavours of the wines they produce). Savennières is associated with bone-dry, mineral and grapefruit-y wines, and Vouvray more for its richer, pear-ish notes – and for wines that vary dramatically in sweetness, which r...
RHJ/iStock via Getty Images On June 30, the silver zero-cost collar that Endeavour Silver ( EXK ) signed in June 2025 expires, as one of the conditions to amend the Terronera Debt Facility, a mine that today produces with an AISC of approximately $22/oz and contributes $84M of quarterly revenue, and which since then has been influencing the company’s silver realization at $42/oz. We are talking ab...
RHJ/iStock via Getty Images On June 30, the silver zero-cost collar that Endeavour Silver ( EXK ) signed in June 2025 expires, as one of the conditions to amend the Terronera Debt Facility, a mine that today produces with an AISC of approximately $22/oz and contributes $84M of quarterly revenue, and which since then has been influencing the company’s silver realization at $42/oz. We are talking about 387,096 oz that during this Q2 will still be settled within a corridor of around $31-$42, and despite the recent correction, silver still remains in a range above $70. This basically means that Endeavour is giving up around $32 per covered ounce below the market, that is, money collected by the counterparty and that comes out of the company’s quarterly cash flow. For me, the operation makes sense, and with the collar now expired, the company mechanically frees up a remainder that needs to be seen to determine whether it is already priced in and could be a potential undiscounted catalyst. For now, the price seems to have taken a break from the rally that began in April of last year, and at the time of writing, with approximately $9.01 per share, it maintains an EV close to $2.8B together with an FWD EV/EBITDA of 6.5x. Data by YCharts This is interesting, as it is behind other comparables such as First Majestic ( AG ), which trades at around 9x, or Pan American ( PAAS ) at around 7.7x, if we take into account that EXK reported one of the best quarters in its history this past May 6. And by this I mean sales of $209.7M, representing an increase of +230% YoY, mine operating earnings of $93.5M, adjusted EBITDA of $108M, and cash rising to $231.8M after the sale of Bolañitos this past January. I do not think there is a clear asymmetry, especially after the macro context we are living through, where the increase in T-Bill yields, in my view, is one of the pieces driving a rotation away from commodities, together with the recent UBS report where they place the silver price for ...
The pitch on the Vanguard Information Technology ETF (NYSEARCA:VGT) is sector breadth. You pay nine basis points, you get the entire information technology sleeve of the U.S. market, roughly $125 billion in assets aggregated into one ticker. So a 50 year old tilting their 401(k) toward tech with VGT thinks they own a sector. They ... VGT Looks Like a Diversified Tech Bet Until You Realize Three St...
The pitch on the Vanguard Information Technology ETF (NYSEARCA:VGT) is sector breadth. You pay nine basis points, you get the entire information technology sleeve of the U.S. market, roughly $125 billion in assets aggregated into one ticker. So a 50 year old tilting their 401(k) toward tech with VGT thinks they own a sector. They ... VGT Looks Like a Diversified Tech Bet Until You Realize Three Stocks Are 43 Percent of It
Grandbrothers/iStock Editorial via Getty Images Bayer ( BAYRY ) ( BAYZF ) announced on Thursday that the U.S. Food and Drug Administration has granted priority review for its marketing application seeking a label expansion for its kidney disease therapy Kerendia. Based on data from its Phase 3 FINE-ONE study, the German conglomerate’s supplemental New Drug Application targets Kerendia’s approval f...
Grandbrothers/iStock Editorial via Getty Images Bayer ( BAYRY ) ( BAYZF ) announced on Thursday that the U.S. Food and Drug Administration has granted priority review for its marketing application seeking a label expansion for its kidney disease therapy Kerendia. Based on data from its Phase 3 FINE-ONE study, the German conglomerate’s supplemental New Drug Application targets Kerendia’s approval for adults with chronic kidney disease associated with type 1 diabetes. The treatment, also known as finerenone, is already available in the U.S. for adults with CKD associated with type 2 diabetes and for heart failure patients with at least 40% of left ventricular ejection fraction. Data published in the New England Journal of Medicine in March indicated that FINE-ONE hit the main goal, as finerenone led to a statistically significant reduction of urine albumin-to-creatinine ratio, an important predictor of kidney events over six months in adults with CKD and T1D. More on Bayer Bayer Aktiengesellschaft (BAYRY) Presents at 21st Annual Global Farm to Market Conference - Slideshow Bayer Aktiengesellschaft 2026 Q1 - Results - Earnings Call Presentation Bayer: Higher Risks From Litigation Drive My Price Target Down Bayer wins FDA priority review for asundexian in stroke and TIA patients Bayer agrees to pay $133M for PCB cleanup in Michigan, Rhode Island
LONDON, May 21, 2026 (GLOBE NEWSWIRE) -- Arqit Quantum Inc. (Nasdaq: ARQQ) (“Arqit” or the “Company”), a global leader in quantum-safe encryption, announces financial results for the first half of fiscal year 2026. Consistent with management’s preliminary assessment of the expected range of revenue, which was announced 10 April 2026, reported revenue for the first half of fiscal year 2026 was $623...
LONDON, May 21, 2026 (GLOBE NEWSWIRE) -- Arqit Quantum Inc. (Nasdaq: ARQQ) (“Arqit” or the “Company”), a global leader in quantum-safe encryption, announces financial results for the first half of fiscal year 2026. Consistent with management’s preliminary assessment of the expected range of revenue, which was announced 10 April 2026, reported revenue for the first half of fiscal year 2026 was $623,000 as of 31 March 2026. Revenue for the period compares favourably to revenue for the comparable period in fiscal year 2025 of $67,000 and revenue for the second half of fiscal year 2025 of $463,000. Revenue was generated from eleven contracts in the first half of fiscal year 2026. For comparison, Arqit generated revenue from seven contracts in the full fiscal year 2025. 3 contracts were with telecom network operators and 8 were with government, defence and enterprise organizations, all key markets for Arqit. The Company has maintained cost discipline with operating costs averaging $2.6 million per month for the period, excluding external legal expenses primarily associated with the previously announced resolution of a shareholder lawsuit. The Company ended the period with cash and cash equivalents of approximately $28.9 million as of 31 March 2026. Cash and cash equivalents as of 20 May 2026 was $35.9 million. In January, Arqit announced the commercial launch of Encryption Intelligence, a completely automated cryptographic inventory solution, which enables continuous discovery and risk prioritisation to help governments and enterprises plan and execute migration to post-quantum cryptography (PQC). In collaboration with Intel, Arqit announced in February the availability of its encryption software pre-installed inside an Intel Trust Domain Extensions (Intel TDX) trusted execution environment (TEE) on Intel Netsec Accelerator Reference Design-based accelerator cards enabling confidential computing for telecom operators and critical national infrastructure. In February, Arq...
Micron Biomedical National and local leaders across government, investors, life science industry and academia acknowledge the impact of Micron’s dissolvable vaccines and therapies on human health and economic development Micron Biomedical’s is clinical-stage biotechnology company developing and manufacturing dissolvable microarray vaccines and therapeutics that overcome access challenges including...
Micron Biomedical National and local leaders across government, investors, life science industry and academia acknowledge the impact of Micron’s dissolvable vaccines and therapies on human health and economic development Micron Biomedical’s is clinical-stage biotechnology company developing and manufacturing dissolvable microarray vaccines and therapeutics that overcome access challenges including needle phobia, clinician shortages in healthcare desserts, and cumbersome cold chain (refrigeration) requirements during storage and transport. The company recently opened a 26,000 square foot commercial-scale manufacturing site in Alpharetta, Georgia for pivotal clinical trials that will accelerate the availability of needle-free vaccines and therapeutics that can be self-administered at home. ALPHARETTA, Ga., May 21, 2026 (GLOBE NEWSWIRE) -- Micron Biomedical today announced the grand opening of its world-class manufacturing facility spanning more than 26,000 square feet in Alpharetta, Georgia. The opening marks the most advanced commercial-scale manufacturing site for Micron’s dissolvable vaccine and therapeutic technology in the world and positions the company for pivotal clinical trials that will accelerate the availability of needle-free vaccines and therapeutics that can be self-administered at home. “A significant body of evidence has shown that our dissolvable microarray technology is as effective as — or more effective than — conventionally injected medicines. Parents, patients, government officials, drug developers, public health leaders, and payers also prefer needle-free vaccines and therapeutics that are simpler and more cost-effective to transport and store,” said Steven Damon, CEO of Micron Biomedical. “Our novel technology requires equally innovative manufacturing equipment capable of scaling production, and this facility brings us one step closer to making that vision a reality.” Micron Biomedical opens commercial-scale manufacturing site in Alpharetta, G...
Sunshine Seeds/iStock via Getty Images Shortly before earnings, I highlighted two companies that I felt were primed to reward shareholders with massive rewards throughout the remainder of 2026. I mentioned in April that I thought that the first quarter earnings were not going to be that exciting, but then most of the focus of conversation would be on the second quarter and beyond. This is because ...
Sunshine Seeds/iStock via Getty Images Shortly before earnings, I highlighted two companies that I felt were primed to reward shareholders with massive rewards throughout the remainder of 2026. I mentioned in April that I thought that the first quarter earnings were not going to be that exciting, but then most of the focus of conversation would be on the second quarter and beyond. This is because oil prices in the 1st quarter were actually depressed, something that sounds completely foreign to us now, with oil consistently hovering around the $100 mark for a barrel using the West Texas Intermediate ( WTI ) crude pricing. It's difficult to imagine that people were genuinely concerned that oil prices were going to fall low enough to cause a strain on producers. Part of the reason for low oil prices to be forecasted was that supply was expected to continue to outpace demand this year and potentially even next year, before demand climbs beyond supply in the future, raising prices. Little did anyone expect the military actions that occurred, both in Venezuela, opening up more supply, and Iran vastly limiting global supply, and the shock it would have on oil prices in both instances. Today, we live in a new paradigm for the moment. Until a peace deal is struck and production can successfully flow from the oil fields to refineries around the world, oil prices will remain elevated due to supply constraints. This means that for oil producers that can generate oil at a low break-even price, all the extra high oil pricing volatility is going to provide them with additional cash flow. I say that with a caveat. If they are a company that hedges their oil prices heavily due to the expectation of low prices, they may not be able to capture the upside effectively. The company I want to look into today uses very limited to no hedging on their oil production, meaning that all this upside volatility we've experienced in 2026 will be pure profit for them. Pure profit for them translate...
anilbolukbas/iStock Editorial via Getty Images V.F. Corporation ( VFC ) has continued to show good progress in the company’s turnaround. The apparel giant’s fiscal Q4 results from the January-March quarter show acceleration in sales growth due to great momentum in Americas. Margin turnaround progress has continued through gross margin gains. Ultimately, the focus remains on Vans, which has failed ...
anilbolukbas/iStock Editorial via Getty Images V.F. Corporation ( VFC ) has continued to show good progress in the company’s turnaround. The apparel giant’s fiscal Q4 results from the January-March quarter show acceleration in sales growth due to great momentum in Americas. Margin turnaround progress has continued through gross margin gains. Ultimately, the focus remains on Vans, which has failed to show meaningful turnaround progress despite some initial signs of improved brand momentum. I maintained a Hold rating in my previous January article on the stock, titled “ V.F. Corp.: The Turnaround Is Advancing ”. The stock has since lost -14% of its value, meanwhile the S&P 500 has gained 6%. My Rating History on VFC (Seeking Alpha) V.F. Q4 Review The V.F. turnaround has gained momentum. V.F. reported improved 3% organic constant currency sales growth in Q4 to a total of $2.17 billion, exceeding the company’s 0-2% growth guidance for the quarter. Growth was again carried by The North Face, as the brand showed impressive 7% constant currency growth to a $935 million topline. Timberland’s growth did slow down to only 2% with sales of $405 million, but The North Face’s momentum was more than offset by other brands’ strength. Growth was consistent across direct-to-consumer and wholesale. VFC Q4'FY26 Investor Presentation Rationalized markdowns, pricing initiatives, and a shift into higher-margin products continue to bolster V.F.’s margins. The gross margin came in at 56.4%, up by 240 basis points from a year ago. Adjusted operating income game in at $54 million, up by $38 million year-on-year despite increased SG&A spending. The margin turnaround is still progressing. The report beat Wall Street’s revenue and EPS expectations by a small margin. V.F.’s strength was led by significant 10% constant currency sales growth in Americas, which I believe to be highly impressive and indicative of the brand portfolio’s strength in the critical U.S. market. The operating environment w...
Shutthiphong Chandaeng/iStock via Getty Images The following segment was excerpted from the Silver Beech Capital Q1 2026 Investor Letter. In this quarter's letter, we have written about our new position in Apollo Global Management ( APO ). In the first quarter, we initiated a large position in Apollo Global Management (("Apollo")). The market has penalized Apollo for its complexity, underappreciat...
Shutthiphong Chandaeng/iStock via Getty Images The following segment was excerpted from the Silver Beech Capital Q1 2026 Investor Letter. In this quarter's letter, we have written about our new position in Apollo Global Management ( APO ). In the first quarter, we initiated a large position in Apollo Global Management (("Apollo")). The market has penalized Apollo for its complexity, underappreciated the durability of its growth, and lumped it in with peers exposed to a wave of private credit anxieties from which we believe Apollo is largely insulated. The convergence of private capital and life insurance is one of the most consequential and durable themes in financial services today, and Apollo is its most structurally advantaged operator due to the pioneering combination of its asset manager and captive life insurer. Business model Apollo's operating model is best understood as three integrated engines: • An alternative asset manager managing capital on behalf of Athene, third-party insurers, institutional investors, and private wealth clients across drawdown funds, perpetual capital vehicles, separately managed accounts, sidecars, and other structures. • A fully integrated life insurer —largely Athene—that originates long-duration life and annuity liabilities, supplying captive, permanent capital. • An origination machine producing credit assets through owned lending platforms ((corporate, real estate, asset-backed, consumer, specialty)), bilateral originations, and bank partnerships. Each engine is a leader in its category. Apollo is a top alternative asset manager by assets under management ((“AUM”)). Athene is the largest issuer of U.S. retail annuities. And Apollo originated more than $300 billion of credit in 2025—a scale exceeded only by a handful of the largest banks. The mechanics: Athene earns spread-related earnings ((“SRE”)) on the gap between asset yields and liability costs, reinvested on its own balance sheet; the asset manager earns fee-related earn...
Getty Images Costco’s ( COST ) in a spot a lot of strong, steady businesses find themselves. The company’s still running smoothly and the business model just keeps working. But the stock price has been pushed so high, almost as if everyone expects nothing but perfection. My last call on this was to Hold . I figured Costco kept hitting all the right notes, steady growth in memberships, healthy sale...
Getty Images Costco’s ( COST ) in a spot a lot of strong, steady businesses find themselves. The company’s still running smoothly and the business model just keeps working. But the stock price has been pushed so high, almost as if everyone expects nothing but perfection. My last call on this was to Hold . I figured Costco kept hitting all the right notes, steady growth in memberships, healthy sales numbers, profits moving up, but the stock price had pulled so far ahead of what the company was actually earning that even good news, or a small upside, was already baked into what people expected. Since I last checked in at $925.55, the share price has first dropped to about $844, before rebounding to $1,074. Costco’s still performing just fine, most of their key numbers are still moving up. COST Membership Strength I’m still neutral for the long haul. The business itself isn’t really in doubt. Paid memberships climbed 4.8% from a year ago. Membership fees reached $2.684 billion in the first half of FY26, including $1.355 billion in Q2. Renewal rates were 92.1% in the U.S. and Canada and 89.7% worldwide. Executive memberships now drive almost three-quarters of sales. Those steady payments are a big reason Costco’s first-half operating cash flow reached $7.684 billion. Net income is $4.036 billion for the first half of FY26. They’re still adding new stores, 924 warehouses are open now and they plan 21 additional new warehouses, including three relocations, in the rest of FY26 and about 942 by year-end. That’s a clear sign they’re still thinking long-term and about growing overseas, too. Online’s not the main profit engine, but it isn’t just a bonus anymore. It’s starting to matter. Ecommerce site traffic jumped 32%. Digitally-enabled comparable sales are up 22.6% year over year, or 21.7% adjusted for FX. Investments in logistics and e-commerce are starting to really make a difference. COST Second-quarter numbers came in strong again, most companies would call these result...
Lemon_tm/iStock via Getty Images Performance The Fund underperformed its blended benchmark (50% S&P 500 Index /10% EAFE Index/40% Bloomberg US Aggregate Bond Index) during the quarter. Market overview Global equity markets, as measured by the MSCI ACWI Index ¹ , ended the quarter modestly higher in US dollar terms. The period was marked by bouts of volatility, driven by concerns over elevated valu...
Lemon_tm/iStock via Getty Images Performance The Fund underperformed its blended benchmark (50% S&P 500 Index /10% EAFE Index/40% Bloomberg US Aggregate Bond Index) during the quarter. Market overview Global equity markets, as measured by the MSCI ACWI Index ¹ , ended the quarter modestly higher in US dollar terms. The period was marked by bouts of volatility, driven by concerns over elevated valuations and uncertainty surrounding returns and financing for large-scale data centre investments. These factors prompted profit-taking in certain mega-cap and AI-related stocks, although the market overall remained resilient. Market leadership shifted towards Health Care, which rallied following the Trump administration's agreement with major pharmaceutical firms to reduce Medicaid drug prices. Procyclical sectors also outperformed, with Materials buoyed by commodity strength and Financials expected to benefit from looser monetary conditions. Emerging markets were the standout performers, supported by a weaker US dollar, lower interest rates and easing trade tensions. Small-cap stocks also performed strongly, reaching new highs, as investors seek out attractive valuations. Fixed income markets shifted from cautious optimism to heightened uncertainty in Q1 2026, as a major energy supply shock collided with a fragile labor market, forcing central banks into a delicate balancing act. The Federal Reserve (Fed) held its target interest rate range steady at 3.50% to 3.75% at both its January and March meetings, pausing the easing cycle that had delivered three consecutive 25 basis point ( BPS ) ² cuts in late 2025. The March Statement of Economic Projections raised 2026 real US GDP growth to 2.4% and lifted both headline and core Personal Consumption Expenditures ³ inflation forecasts to 2.7%, reflecting uncertainty tied to the conflict with Iran. The dot plot continued to signal one interest rate cut for 2026, consistent with futures market pricing by quarter-end. Market overvie...
A spike in fertilizer costs driven by the Iran war is hitting farmers in agriculture powerhouse Brazil at the worst possible time, underscoring how the Middle East conflict is threatening global food supplies. Brazilian farmers have already been grappling with lower commodity prices, limited access to credit, elevated debt , unfavorable currency exchange rates and surging costs of moving goods to ...
A spike in fertilizer costs driven by the Iran war is hitting farmers in agriculture powerhouse Brazil at the worst possible time, underscoring how the Middle East conflict is threatening global food supplies. Brazilian farmers have already been grappling with lower commodity prices, limited access to credit, elevated debt , unfavorable currency exchange rates and surging costs of moving goods to ports. Now the rapid rise in fertilizer is taking things to a tipping point, and many growers are rethinking investments in land and crop inputs as they look ahead to the next planting season. Take for example soybeans, the nation’s top crop. Acreage will expand by the slowest rate in nearly 20 years for the season that starts in September, according to market intelligence company Veeries. Consultancy Agroconsult gave a similar outlook recently, while an estimate from analysts at Datagro forecasts the lowest growth in a decade. “Anyone who watched agribusiness in the past 10 years had always viewed the sector as prosperous and growing,” said Marcos Rubin, founder of market intelligence company Veeries. “That’s not the environment now.” It’s a shift that has the potential to ripple through the global agriculture landscape. The country’s abundant, low-cost soybeans have helped boost international stockpiles of the oilseed used in cooking oil and animal feed. The nation is the top supplier to China, the world’s biggest crop buyer. Slowdowns in Brazil could mean added food inflation in Asia and beyond as importers compete for supplies. Within Brazil, pessimism in the agriculture industry is widespread. Farmer sentiment as calculated by Bloomberg Intelligence has dropped to the lowest in more than a year. The situation presents a political challenge for president Luiz Inacio Lula da Silva , who is running for reelection. Agriculture accounts for about a quarter of Brazil’s gross domestic product by some measures, and distressed farmers are looking for more subsidized credit, alo...